DK0810878T3 - RNA-fotospaltning ved anvendelse af texaphyriner - Google Patents

RNA-fotospaltning ved anvendelse af texaphyriner

Info

Publication number
DK0810878T3
DK0810878T3 DK96919188T DK96919188T DK0810878T3 DK 0810878 T3 DK0810878 T3 DK 0810878T3 DK 96919188 T DK96919188 T DK 96919188T DK 96919188 T DK96919188 T DK 96919188T DK 0810878 T3 DK0810878 T3 DK 0810878T3
Authority
DK
Denmark
Prior art keywords
texaphyrin
cleavage
rna
site
polymer
Prior art date
Application number
DK96919188T
Other languages
Danish (da)
English (en)
Inventor
Darren Magda
Jonathan L Sessler
Original Assignee
Pharmacyclics Inc
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Inc, Univ Texas filed Critical Pharmacyclics Inc
Application granted granted Critical
Publication of DK0810878T3 publication Critical patent/DK0810878T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96919188T 1995-06-07 1996-05-31 RNA-fotospaltning ved anvendelse af texaphyriner DK0810878T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,551 US5714328A (en) 1995-06-07 1995-06-07 RNA photocleavage using texaphyrins
PCT/US1996/009419 WO1996040253A2 (en) 1995-06-07 1996-05-31 Rna photocleavage using texaphyrins

Publications (1)

Publication Number Publication Date
DK0810878T3 true DK0810878T3 (da) 1999-10-11

Family

ID=23924628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919188T DK0810878T3 (da) 1995-06-07 1996-05-31 RNA-fotospaltning ved anvendelse af texaphyriner

Country Status (14)

Country Link
US (1) US5714328A (ja)
EP (1) EP0810878B1 (ja)
JP (2) JPH10510844A (ja)
KR (1) KR100355251B1 (ja)
AT (1) ATE177951T1 (ja)
AU (1) AU694051B2 (ja)
CA (1) CA2218477C (ja)
DE (1) DE69601865T2 (ja)
DK (1) DK0810878T3 (ja)
ES (1) ES2130826T3 (ja)
GR (1) GR3030257T3 (ja)
NO (1) NO975312L (ja)
NZ (1) NZ310739A (ja)
WO (1) WO1996040253A2 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5969111A (en) * 1994-04-14 1999-10-19 Board Of Regents, The University Of Texas System Texaphyrins substituted with imidazole are provided
AU730154B2 (en) 1995-10-27 2001-03-01 Elliot R. Ramberg Methods and compositions for detection of specific nucleotide sequences
US5776925A (en) * 1996-01-25 1998-07-07 Pharmacyclics, Inc. Methods for cancer chemosensitization
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
AU5237798A (en) * 1997-05-14 1998-12-08 Sergy Mykolaiovytch Khrapunov Method for treatment of deoxyribonucleic acid sequence by restrictase
US6022526A (en) * 1997-07-30 2000-02-08 Pharmacyclics, Inc. Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
JP4207258B2 (ja) 1998-08-31 2009-01-14 東ソー株式会社 特定核酸配列の切断方法
US6284220B1 (en) 1999-06-03 2001-09-04 The General Hospital Corporation Noninvasive imaging of nucleic acid vectors
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6638924B2 (en) 2000-08-30 2003-10-28 Pharmacyclics, Inc. Metallotexaphyrin derivatives
WO2002017925A1 (en) * 2000-08-30 2002-03-07 Pharmacyclics, Inc. Non-symmetric tripyrrannes in the synthesis of novel macrocycles
US7449454B2 (en) * 2000-08-30 2008-11-11 Pharmacyclics, Inc. Metallotexaphyrin derivatives
US7263445B2 (en) * 2000-12-13 2007-08-28 Karsten Koenig Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular DNA
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003072581A1 (en) 2002-02-26 2003-09-04 Board Of Regents, The University Of Texas System Cyclo[n]pyrroles and methods thereto
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
JP2006224318A (ja) * 2005-02-15 2006-08-31 Brother Ind Ltd インクジェット記録装置
US20070072838A1 (en) 2005-09-26 2007-03-29 Pharmacyclics, Inc. High-purity texaphyrin metal complexes
US20070078119A1 (en) * 2005-09-30 2007-04-05 Pharmacyclics, Inc. Storage system for texaphyrin pharmaceutical formulations
US8133474B2 (en) * 2006-09-15 2012-03-13 Massachusetts Institute Of Technology Sensors for fluorescence and magnetic resonance imaging
US20140127077A1 (en) 2012-11-05 2014-05-08 Gail Rock Device and method for sterilization of instruments and surfaces

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318825A (en) * 1979-08-15 1982-03-09 Frame Robert R Catalytic composite, and method of manufacture
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
FR2586704B1 (fr) * 1985-09-04 1987-12-18 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation et a un groupe chimique activable, leur synthese et leurs applications a titre de nucleases artificielles specifiques de sequences. centre national de la recherche scientifique (cnrs)
CA1315780C (en) * 1986-01-17 1993-04-06 Yozo Fukuda Porphyrin derivatives
US5242797A (en) * 1986-03-21 1993-09-07 Myron J. Block Nucleic acid assay method
US4915683A (en) * 1986-11-21 1990-04-10 The Medical College Of Wisconsin, Inc. Antiviral method, agents and apparatus
US5135717A (en) * 1986-12-24 1992-08-04 British Technology Group Usa Inc. Tetrabenztriazaporphyrin reagents and kits containing the same
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
EP0396651A4 (en) * 1988-07-28 1990-12-12 Best Industries, Inc. Device and method for encapsulating radioactive materials
EP0434727A4 (en) * 1988-09-08 1994-08-17 Ultra Diagnostic Corp Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents
US5041078A (en) * 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
US5272142A (en) * 1989-03-06 1993-12-21 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5252720A (en) * 1989-03-06 1993-10-12 Board Of Regents, The University Of Texas System Metal complexes of water soluble texaphyrins
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5256399A (en) * 1989-03-06 1993-10-26 Board Of Regents, The University Of Texas System Aromatic pentadentate expanded porphyrins in magnetic resonance imaging
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US5599923A (en) * 1989-03-06 1997-02-04 Board Of Regents, University Of Tx Texaphyrin metal complexes having improved functionalization
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
FR2650761B1 (fr) * 1989-08-10 1994-03-04 Elf Aquitaine Ste Nale Catalyseur d'oxydation a base de metalloporphyrine sur support
US5219732A (en) * 1989-09-05 1993-06-15 The Regents Of The University Of California Antibody-mediated cofactor-driven reactions
US5159065A (en) * 1989-12-21 1992-10-27 Board Of Regents, The University Of Texas System Sapphyrins, derivatives and syntheses
US5457195A (en) * 1989-12-21 1995-10-10 Board Of Regents, The University Of Texas System Sapphyrin derivatives and conjugates
EP0533753A1 (en) * 1990-06-14 1993-03-31 Washington University Rna hydrolysis/cleavage
US5272056A (en) * 1991-01-03 1993-12-21 The Research Foundation Of State University Of New York Modification of DNA and oligonucleotides using metal complexes of polyaza ligands
US5607924A (en) * 1992-01-21 1997-03-04 Pharmacyclics, Inc. DNA photocleavage using texaphyrins
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
FR2697254A1 (fr) * 1992-10-22 1994-04-29 Genset Sa Conjugués constitués par un oligonucléotide lié à des dérivés de métalloporphyrine cationique, leur préparation et leur utilisation.
EP0758250A1 (en) * 1994-04-28 1997-02-19 The Board Of Regents, The University Of Texas System Texaphyrin solid-supports and devices
HUT77034A (hu) * 1994-09-02 1998-03-02 Novartis Ag. Ribonukleinsavak hasítására szolgáló oligonukleotid konjugátumok, készítmények és eljárás

Also Published As

Publication number Publication date
DE69601865D1 (de) 1999-04-29
NO975312L (no) 1998-02-05
JP2001316270A (ja) 2001-11-13
ATE177951T1 (de) 1999-04-15
AU694051B2 (en) 1998-07-09
NZ310739A (en) 2000-09-29
KR19980701473A (ko) 1998-05-15
KR100355251B1 (ko) 2003-02-17
AU6159096A (en) 1996-12-30
US5714328A (en) 1998-02-03
NO975312D0 (no) 1997-11-19
JPH10510844A (ja) 1998-10-20
EP0810878B1 (en) 1999-03-24
DE69601865T2 (de) 1999-08-05
GR3030257T3 (en) 1999-08-31
CA2218477A1 (en) 1996-12-19
EP0810878A2 (en) 1997-12-10
ES2130826T3 (es) 1999-07-01
CA2218477C (en) 2002-10-22
WO1996040253A3 (en) 1997-01-23
WO1996040253A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
DK0810878T3 (da) RNA-fotospaltning ved anvendelse af texaphyriner
Knorre et al. Complementary-addressed (sequence-specific) modification of nucleic acids
Peck-Miller et al. Kinetics of the processing of the precursor to 4· 5 S RNA, a naturally occurring substrate for RNase P from Escherichia coli
Garegg et al. Nucleoside H-phosphonates. IV. Automated solid phase synthesis of oligoribonucleotides by the hydrogenphosphonate approach
EP0967274A3 (de) Verfahren zur Reinigung von kovalent geschlossenen DNA-Molekülen
UA49843C2 (uk) Олігонуклеотид для ампліфікації послідовностей нуклеїнових кислот, спосіб ампліфікації цільової послідовності нуклеїнової кислоти, набір для здійснення реакції ампліфікації нуклеїнової кислоти
Pratviel et al. Nonenzymic cleavage and ligation of DNA at a three A. cntdot. T base pair site. A two-step pseudohydrolysis of DNA
EP1602725A3 (en) Abasic-nucleotide containing enzymatic nucleic acid
Jones et al. Dual action of tirapazamine in the induction of DNA strand breaks
Rabin et al. Analysis of RNA secondary structure by photochemical reversal of psoralen crosslinks
WO1994029316A3 (en) Texaphyrin metal complex mediated ester hydrolysis
BR9306252A (pt) Processo para modificaçao enzimática de macromolécula biológica
WO1998054313A3 (en) Dna methyltransferase genomic sequences and antisense oligonucleotides
Kleineidam et al. Efficient cleavage of pre-tRNAs by E. coli RNAse P RNA requires the 2′-hydroxyl of the ribose at the cleavage site
EP1006200A3 (en) Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
Vasseur et al. Derivatization of oligonucleotides through abasic site formation
Carriero et al. Template-mediated synthesis of lariat RNA and DNA
Greenberg Tandem and clustered lesions from radicals in nucleic acids from a single initial chemical event
Markham et al. Rapid chemical synthesis and circular dichroism properties of some 2′-5′-linked oligoriboadenylates
Bull et al. Inactivation of E. coli RNA polymerase by pyridoxal 5′-phosphate: Identification of a low pKa lysine as the modified residue
Boutorine et al. Effect of the terminal phosphate derivatization of β-and α-oligodeoxynucleotides on their antisense activity in protein biosynthesis, stability and uptake by eucaryotic cells
Von Sonntag Radiation chemistry in the 1990s: pressing questions relating to the areas of radiation biology and environmental research
Agrawal et al. Mixed-backbone oligonucleotides containing phosphorothioate and methylphosphonate linkages as second generation antisense oligonucleotide
Küpfer et al. RNA Abasic Sites: Preparation and Trans‐Lesion Synthesis by HIV‐1 Reverse Transcriptase
HK1030887A1 (en) Treatment of bladder cancer by mycobacterium phleicell wall.